{"id":"NCT00660907","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients","officialTitle":"A 52-Week International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III Study With a 156-Week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin in Combination With Metformin Compared With Sulphonylurea in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy Alone.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2009-12","completion":"2013-01","firstPosted":"2008-04-17","resultsPosted":"2013-08-23","lastUpdate":"2015-03-30"},"enrollment":1217,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"dapagliflozin","otherNames":[]},{"type":"DRUG","name":"glipizide","otherNames":["Glucotrol"]},{"type":"DRUG","name":"metformin hydrochloride","otherNames":["Glucophage"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This study is being carried out to see if dapagliflozin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glipizide (sulphonylurea) as an addition to metformin treatment.","primaryOutcome":{"measure":"Adjusted Mean Change in HbA1c Levels","timeFrame":"Baseline to Week 52","effectByArm":[{"arm":"Dapagliflozin Plus Metformin","deltaMin":-0.52,"sd":null},{"arm":"Glipizide Plus Metformin","deltaMin":-0.52,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":76,"countries":["Argentina","France","Germany","Italy","Mexico","Netherlands","South Africa","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["21816980","23529570"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=289&filename=CSR-D1690C00004.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":406},"commonTop":["Hypoglycemia","Nasopharyngitis","Hypertension","Influenza","Upper Respiratory Tract Infection"]}}